NA2 Stock Overview
Engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Natural Alternatives International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.26 |
| 52 Week High | US$6.60 |
| 52 Week Low | US$3.80 |
| Beta | 0.59 |
| 11 Month Change | 6.50% |
| 3 Month Change | -10.88% |
| 1 Year Change | -18.86% |
| 33 Year Change | -62.63% |
| 5 Year Change | -39.57% |
| Change since IPO | -25.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| NA2 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 9.2% | -0.06% | 0.9% |
| 1Y | -18.9% | -6.5% | 7.7% |
Return vs Industry: NA2 underperformed the German Personal Products industry which returned -6.5% over the past year.
Return vs Market: NA2 underperformed the German Market which returned 7.7% over the past year.
Price Volatility
| NA2 volatility | |
|---|---|
| NA2 Average Weekly Movement | 10.1% |
| Personal Products Industry Average Movement | 3.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NA2's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: NA2's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 296 | Mark LeDoux | www.nai-online.com |
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.
Natural Alternatives International, Inc. Fundamentals Summary
| NA2 fundamental statistics | |
|---|---|
| Market cap | €26.22m |
| Earnings (TTM) | -€8.04m |
| Revenue (TTM) | €106.76m |
0.2x
P/S Ratio-3.3x
P/E RatioIs NA2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NA2 income statement (TTM) | |
|---|---|
| Revenue | US$112.98m |
| Cost of Revenue | US$106.99m |
| Gross Profit | US$5.99m |
| Other Expenses | US$14.49m |
| Earnings | -US$8.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.44 |
| Gross Margin | 5.30% |
| Net Profit Margin | -7.53% |
| Debt/Equity Ratio | 18.2% |
How did NA2 perform over the long term?
See historical performance and comparison